Literature DB >> 3161325

The adolescent with essential hypertension.

A B Gruskin.   

Abstract

Clinical features in a comparably studied group of hypertensive and normotensive adolescents are described. Hypertensive hyperreninemia occurred in four of 28 hypertensive adolescents; suppressed plasma renin activity was found in five of 27 hypertensive adolescents. Only one of five adolescents identified as having suppressed plasma renin activity after ingesting a low-salt diet for three days had a hyporesponsive response to acute extracellular volume contraction. Pressure natriuresis was documented in six of 32 adolescents. Compared to normotensive, the hypertensive group was found to have elevated levels of serum uric acid. Plasma renin activity was higher in hypertensive children with hyperuricemia than in those with normouricemia. The hypertensive adolescents also had higher levels of serum calcium and phosphorus. Two-thirds of the hypertensive adolescents had echocardiographic changes of myocardial hypertrophy. No ophthalmologic nor renal abnormalities were documented in the hypertensive group. A review of factors influencing blood pressure changes during childhood and current considerations for therapy are included.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161325     DOI: 10.1016/s0272-6386(85)80146-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.

Authors:  Shigemasa Tani; Ken Nagao; Atsushi Hirayama
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

2.  Essential hypertension vs. secondary hypertension among children.

Authors:  Monesha Gupta-Malhotra; Ashish Banker; Sanjay Shete; Syed Sharukh Hashmi; John E Tyson; Michelle S Barratt; Jacqueline T Hecht; Diane M Milewicz; Eric Boerwinkle
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

3.  The role of uric acid in pediatric hypertension.

Authors:  Daniel I Feig; Richard J Johnson
Journal:  J Ren Nutr       Date:  2007-01       Impact factor: 3.655

4.  Characteristics of children with primary hypertension seen at a referral center.

Authors:  Joseph T Flynn; Michael H Alderman
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

Review 5.  Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.

Authors:  Miriam B Vos; Jill L Kaar; Jean A Welsh; Linda V Van Horn; Daniel I Feig; Cheryl A M Anderson; Mahesh J Patel; Jessica Cruz Munos; Nancy F Krebs; Stavra A Xanthakos; Rachel K Johnson
Journal:  Circulation       Date:  2016-08-22       Impact factor: 29.690

Review 6.  Uric acid and hypertension.

Authors:  Daniel I Feig; Duk-Hee Kang; Takahiko Nakagawa; Marilda Mazzali; Richard J Johnson
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

7.  Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.

Authors:  Kyle E Rodenbach; Michael F Schneider; Susan L Furth; Marva M Moxey-Mims; Mark M Mitsnefes; Donald J Weaver; Bradley A Warady; George J Schwartz
Journal:  Am J Kidney Dis       Date:  2015-07-21       Impact factor: 8.860

8.  Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Authors:  Daniel I Feig; Beth Soletsky; Richard J Johnson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

9.  Hyperuricemia in childhood primary hypertension.

Authors:  Daniel I Feig; Richard J Johnson
Journal:  Hypertension       Date:  2003-08-04       Impact factor: 10.190

Review 10.  The role of uric acid in the pathogenesis of hypertension in the young.

Authors:  Daniel I Feig
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.